MEDB-26. Outcomes of children with standard-risk and high-risk medulloblastoma treated with pre-irradiation chemotherapy and risk-adapted craniospinal irradiation: a report on patients from the Polish Pediatric Neuro-oncology Group

BACKGROUND: The last two decades have witnessed several efforts to minimize the adverse sequelae of craniospinal irradiation (CSI), a standard of care treatment modality in medulloblastoma. This has been accomplished by adding chemotherapy to the treatment backbone. The use of pre-irradiation chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Perek-Polnik, Marta, Cochrane, Anne, Chojnacka, M, Drogosiewicz, M, Filipek, I, Swieszkowska, E, Tarasinska, M, Kowalczyk, P, Abdelbaki, Mohamed S, Dembowska-Bagińska, Bożenna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Medulloblastoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165299/
http://dx.doi.org/10.1093/neuonc/noac079.400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165299/
http://dx.doi.org/10.1093/neuonc/noac079.400

Ejemplares similares